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CRC screening by gender were mixed, but qualitative stud-
ies highlighted fear of experimentation and intrusiveness of 
screening methods as unique themes among African Amer-
ican men. Limitations include heterogeneity in mistrust and 
CRC measures, and possible publication bias. Future stud-
ies should address methodological challenges found in this 
review, such as limited use of validated and reliable mis-
trust measures, examination of CRC screening outcomes 
beyond beliefs and intent, and a more thorough analysis of 
gender roles in the cancer screening process.
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Background
Colorectal cancer (CRC) is the second leading cause of 
cancer-related deaths in the United States, and approxi-
mately 51,000 Americans die each year from this disease 
[1]. National guidelines from the U.S. Preventive Services 
Task Force (USPSTF) and the American Cancer Society 
recommend screening for CRC using fecal occult blood 
testing  (FOBT), sigmoidoscopy, or colonoscopy among 
average risk adults [2]. Adherence to these screening rec-
ommendations, which are in place for asymptomatic indi-
viduals between 50 and 75 years old, has been associated 
with a net reduction in CRC incidence and improved sur-
vival rate among the general population. However, these 
commonly adopted recommendations do not offer tar-
geted strategies for individuals at highest risk for devel-
oping colorectal cancer. African Americans have a higher 
incidence of and mortality from CRC, and also experi-
ence greater morbidity and lower quality of health care 
compared with non-Hispanic Whites [3, 4]. Given these 
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Abstract Despite well-documented benefits of colo-
rectal cancer (CRC) screening, African Americans are 
less likely to be screened and have higher CRC incidence 
and mortality than Whites. Emerging evidence suggests 
medical mistrust may influence CRC screening dispari-
ties among African Americans. The goal of this systematic 
review was to summarize evidence investigating associa-
tions between medical mistrust and CRC screening among 
African Americans, and variations in these associations by 
gender, CRC screening type, and level of mistrust. MED-
LINE, CINAHL, Web of Science, PsycINFO, Google 
Scholar, Cochrane Database, and EMBASE were searched 
for English-language articles published from January 
2000 to November 2016. 27 articles were included for this 
review (15 quantitative, 11 qualitative and 1 mixed meth-
ods study). The majority of quantitative studies linked 
higher mistrust scores with lower rates of CRC screening 
among African Americans. Most studies examined mistrust 
at the physician level, but few quantitative studies analyzed 
mistrust at an organizational level (i.e. healthcare systems, 
insurance, etc.). Quantitative differences i n m istrust and 
Electronic supplementary material The online version of this 
article (doi:10.1007/s10900-017-0339-2) contains supplementary 
material, which is available to authorized users.
 Wizdom Powell
wizdomp@email.unc.edu
1 Department of Health Behavior, UNC Gillings School 
of Global Public Health, Chapel Hill, NC, USA
2 Center for Health Equity Research, University of North 
Carolina at Chapel Hill, Chapel Hill, NC, USA
3 Department of Social Medicine, UNC School of Medicine, 
University of North Carolina at Chapel Hill, Chapel Hill, NC, 
USA
disparities in outcomes, access and timely use of approved 
screening procedures is of critical importance among Afri-
can Americans.
In fact, despite the life-saving potential and enhanced net 
benefits of screening, approximately 27.7% of Americans 
age 50–75 have not received timely screening for colorec-
tal cancer [5] and African Americans have a lower uptake 
of CRC screening than non-Hispanic whites [6–8]. Racial 
disparities in CRC screening adherence are further exac-
erbated by gender, with African American men exhibiting 
a lower likelihood of being screened than African Ameri-
can women [9, 10]. Economic and interpersonal factors 
associated with reduced uptake of CRC screening among 
African Americans have been well documented in previous 
empirical studies and include poor patient/provider com-
munication and socioeconomic challenges, such as insur-
ance status, socioeconomic status, and cost, in obtaining 
quality CRC screening [11, 12]. However, emerging litera-
ture also identifies psychosocial influences, such as cultural 
norms, differential perceptions of risk, and negatives atti-
tudes towards healthcare, as primary barriers to receiving 
timely colorectal cancer screening in the African American 
population [6, 13]. Among these factors, lack of trust in the 
healthcare system remains a paramount psychosocial influ-
ence for reduced uptake of cancer screening in the United 
States [14]. Mistrust of the healthcare system and its pro-
viders, also known as medical mistrust, is associated with 
lower health services utilization among African American 
patients [15, 16] and is a widely cited attitudinal barrier to 
CRC screening and treatment seeking [17].
Many studies consider mistrust from an interpersonal 
perspective, assessing this construct specifically within 
the patient-provider relationship. However, medical mis-
trust also reflects a belief system that, because of historical 
and lived experiences, patients are guarded about organi-
zational-level policies and healthcare system procedures 
[18]. Investigations measuring medical mistrust at the phy-
sician and organizational levels and their associations with 
cancer screening appear to yield conflicting results [19, 
20]. Organizational-level mistrust has also only recently 
received focused empiric attention, and its impact on can-
cer screening has not been thoroughly explored. As a result, 
less is known about its contribution to poor CRC screening 
uptake among African Americans. In addition, as African 
American men report higher levels of medical mistrust than 
African American women [21, 22] it is important to syn-
thesize what is known about gender differences in associa-
tions between medical mistrust and CRC screening.
The primary goal of this study is to systematically 
review studies investigating associations between medi-
cal mistrust, at both the physician and organizational level, 
and uptake of CRC screening among African Americans. 
To examine whether medical mistrust has a significant 
influence on colorectal cancer screening patterns among 
African Americans, we reviewed empirical literature 
assessing the role of mistrust in providers or the healthcare 
system to determine whether this indicator has an impact 
on CRC screening utilization, beliefs, and attitudes among 
African Americans in the United States. Additionally, we 
examined gender differences in medical mistrust as well as 
preferred methods of CRC screening (e.g. FOBT, colonos-
copy, etc.) within this population. We specifically address 
the following key questions:
KQ1: How does mistrust of health care providers and/or 
organizations impact CRC screening behavior among Afri-
can Americans?
KQ2: How does medical mistrust differentially impact 
CRC screening patterns among African American men and 
women?
KQ3: How does medical mistrust impact the types of 
CRC screening African Americans receive (e.g., FOBT, 
colonoscopy, or flexible sigmoidoscopy)?
KQ4: Is there a differential impact on CRC screening 
behavior depending on whether mistrust is measured at the 
individual provider or organization level?
Methods
An a priori study protocol was submitted to PROSPERO 
to guide implementation of the review. Original, empiri-
cal studies investigating medical mistrust and colorectal 
cancer screening outcomes published from January 2000 
to November 2016 were examined for this study. Studies 
with a sample of African American adult participants and 
a measure or theme related to physician or health organi-
zation mistrust were included in our study. The primary 
outcome of interest was CRC screening outcomes (i.e., 
screening—receipt: yes/no, beliefs, knowledge, and atti-
tudes towards screening). We searched MEDLINE (Pub-
med), CINAHL, Web of Science, PsycINFO, Google 
Scholar, Cochrane Database, and EMBASE. Search strate-
gies for each database were developed in coordination with 
a research librarian specializing in systematic reviews. We 
limited searches to articles published in English and used 
search terms and Medical Subject Headings (MeSH) terms 
related to colorectal cancer, African Americans, and mis-
trust (See online material). We also included search terms 
for various types of CRC screening methods (i.e. FOBT, 
colonoscopy, etc.). Additional studies were also included 
by examining reference lists of included studies.
Two investigators independently screened abstracts and 
titles for inclusion to the full text review. Full text articles 
were screened by the same two investigators. Discrepan-
cies between investigators were resolved by consensus at 
team meetings. We included studies using the following 
criteria: Studies must (1) Only include human subjects 
and be published in English; (2) Be empirical or analyti-
cal studies; (3) Be conducted in the United States; (4) Be 
published between January 2000 (two years before the 
USPSTF’s recommendations for CRC screening starting at 
age 50 or older were published) and November 2016; (5) 
Include African Americans; (6) Discuss changes in CRC 
screening outcomes. Alternatively, studies were excluded 
if they: (1) Were commentaries or non-empirical stud-
ies; (2) Focus exclusively on foreign born Blacks or other 
racial/ethnic groups; (3) Focus solely on policy reviews and 
implementation.
Subgroup analyses were pre-specified in the Key Ques-
tions. The impact of medical mistrust on colorectal can-
cer screening rates was stratified by gender. This analysis 
was conducted to clarify gender differences in associations 
between medical mistrust and CRC screening outcomes. 
Additionally, we stratified data by preferred colorectal can-
cer screening type (i.e. FOBT, colonoscopy, etc.). Finally, 
articles examining medical mistrust of providers and those 
measuring mistrust of the healthcare system were com-
pared to determine if differences emerged in their associa-
tion with CRC screening.
Adherence to CRC screening guidelines (e.g. com-
pleted a colonoscopy/FOBT/etc. or not) was the primary 
outcome measure of this study. We also included studies 
that assessed attitudes or beliefs regarding CRC screening, 
such as intention to screen. We used a descriptive approach 
to summarize study characteristics and outcomes for all 
research questions. For each quantitative study, we exam-
ined the direction of association between medical mistrust 
and CRC screening. For qualitative studies, we identified 
common themes associated with medical mistrust within 
participant responses. Findings disaggregated by gender 
and level of mistrust (e.g. provider or organizational) were 
also highlighted in order to assess Key Questions 2 and 4.
Results
Study Selection
Figure  1 provides details regarding the article selection 
and inclusion process. The overall database search yielded 
777 articles. We included an additional 19 articles rel-
evant to our research questions from reference lists of 
included studies. After adjusting for duplicates, a total of 
598 original articles were yielded from the initial database 
search, and the title and abstracts of these articles were 
reviewed. 476 articles were excluded during the title and 
abstract screening because they did not meet our inclu-
sion criteria. We retrieved 122 full-text articles for further 
review and excluded another 95 articles, leaving 27 
articles 
representing 26 unique studies for further analysis. None of 
the studies obtained from our manual search of reference 
lists from our included studies were eligible for inclusion. 
Of the 27 included articles, 15 were quantitative, 11 were 
qualitative, and one was mixed methods.
Study Characteristics of Included Studies
Characteristics of included studies are described in Table 1. 
The majority (37%) of studies were cross-sectional designs, 
followed by focus groups (30%). Two studies were rand-
omized control trials. Sample sizes of the included studies 
ranged from 14 to 55 participants for qualitative studies, 
and 43 to 961 participants for quantitative studies. Arti-
cles generally focused on FOBT, colonoscopy, and sig-
moidoscopy, and these screening outcomes were primar-
ily assessed through self-reported surveys measuring past 
screening behavior or intention to screen. Only two articles 
measured CRC screening directly through methods such as 
chart audits or FOBT card return. While almost all articles 
focused on mistrust measured at the physician level (96%), 
15 articles (56%) assessed both physician and organiza-
tion levels of mistrust. Other outcomes addressed in stud-
ies included: knowledge of CRC risk factors, cancer fatal-
ism, physician recommendation, and self-rated health. The 
majority of articles (59%) included only African American 
participants in the sample, and most articles (59%) sampled 
individuals who were 50 years of age and older. Eleven 
articles included participants who were younger than age 
50, and one of these articles assessed CRC screening atti-
tudes and beliefs among participants that were 18 years or 
older. Six articles (22%) sampled individuals who were not 
up to date with colorectal cancer screening or who were 
currently eligible for their next regular screening. Two arti-
cles (8%) sampled individuals who were first degree rela-
tives of someone diagnosed with colorectal cancer.
Dominant Themes from Qualitative Studies
Table  2 summarizes the dominant themes in the qualita-
tive studies included in this review. In nine qualitative 
articles, participants noted their mistrust of doctors and/
or the health care system during discussions about barriers 
to CRC screening. In five articles, participants expressed 
skepticism of provider motives for recommending colorec-
tal cancer screening (e.g., that doctors might recommend 
screening unnecessarily to make money from conducting 
the procedure). In three articles, participants expressed mis-
trust of some providers’ competence and training as well 
as the quality of care they received from the health care 
system. Similarly, in three articles, participants expressed 
worry that health care providers might treat them unfairly 
or give them poor quality treatment due to their race, eth-
nicity, gender, or socioeconomic status.
In terms of qualitative differences by gender, themes 
were similar across articles for men and women. However, 
African American men expressed more explicit fears of 
medical experimentation and uneasiness about the inva-
siveness of colorectal cancer screening procedures, such as 
colonoscopies.
Psychometric Properties of Trust Scales
Table 3 provides information about the trust scale proper-
ties used in the included quantitative studies. Eight different 
scales were used in the articles included in this review. Five 
of these scales measured trust in physicians/providers, one 
scale measured trust in the health care system, one scale 
measured trust in both health care providers and the health 
care system, and one scale measured trust in patient naviga-
tors. No specific scale was used predominantly across the 
articles; however, the most frequently used measure was 
the Group-Based Medical Mistrust Scale (n  =  3). Most 
studies did not report measures of scale reliability or valid-
ity. However, some studies measured scale reliability and 
reported Cronbach’s alphas. Of those studies, most reported 
Cronbach’s alpha coefficients of above 0.80.
Two studies listed items used to measure trust that were 
not from a specific scale. Bynum et al. [31] used the item 
“How much does lack of trust in medical people inter-
fere with your taking part in a cancer screening exam?” 
Gordon et  al. [24] asked respondents if they would get a 
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an
d 
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ei
ve
d 
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d 
w
he
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r C
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fic
it
68
.8
%
40
 a
nd
 o
ld
er
29
3
FO
B
T,
 c
ol
on
os
-
co
py
, s
ig
m
oi
-
do
sc
op
y
Ph
ys
ic
ia
n
Tr
us
t i
n 
he
al
th
 
ca
re
 p
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ic
an
 A
m
er
i-
ca
n 
m
en
 a
nd
 
w
om
en
 a
ge
 
40
+
 w
ith
 a
t 
le
as
t o
ne
 fi
rs
t-
de
gr
ee
 fa
m
ily
 
m
em
be
r 
aff
ec
te
d 
by
 
C
RC
10
0%
40
 a
nd
 o
ld
er
; 
fir
st 
de
gr
ee
 
re
la
tiv
es
14
C
ol
on
os
co
py
Ph
ys
ic
ia
n 
an
d 
or
ga
ni
za
tio
n
N
/A
N
/A
G
up
ta
 e
t a
l. 
[4
7]
Q
ua
nt
ita
tiv
e
Pr
os
pe
ct
iv
e
Pa
tie
nt
s a
ge
s 
50
+
 n
ot
 
cu
rr
en
t w
ith
 
sc
re
en
in
g
17
.8
%
50
 a
nd
 o
ld
er
70
1
FO
B
T 
an
d 
co
lo
no
sc
op
y
Ph
ys
ic
ia
n 
an
d 
or
ga
ni
za
tio
n
W
ak
e 
Fo
re
st 
Tr
us
t
C
RC
 sc
re
en
in
g 
co
m
pl
et
io
n 
w
ith
in
 1
2 
m
on
th
s f
ol
lo
w
-
in
g 
en
ro
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Sa
m
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s
R
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ro
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m
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f c
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 c
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ve
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 o
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in
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or
H
ol
m
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 a
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Q
ua
lit
at
iv
e
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cu
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A
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ic
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m
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W
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B
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N
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N
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t a
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Q
ua
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ita
tiv
e
R
an
do
m
iz
ed
 
co
nt
ro
l t
ria
l
A
fr
ic
an
 A
m
er
i-
ca
n 
pa
tie
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s 
ag
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re
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rr
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r 
co
lo
no
sc
op
y 
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re
en
in
g
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 a
nd
 o
ld
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os
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us
t i
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-
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r
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us
t i
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-
to
r s
ca
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C
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et
io
n 
of
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lo
no
sc
op
y 
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te
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in
ed
 b
y 
ch
ar
t a
ud
it
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ss
er
 e
t a
l. 
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9]
Q
ua
lit
at
iv
e
Se
m
i-s
tru
ct
ur
ed
 
In
te
rv
ie
w
s
O
ut
pa
tie
nt
s 
ag
es
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ho
 
w
er
e 
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ig
ib
le
 
fo
r c
ol
or
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ta
l 
ca
nc
er
 sc
re
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in
g
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 a
nd
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ld
er
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on
os
co
py
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B
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ic
ia
n
N
/A
N
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m
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in
s e
t a
l. 
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Q
ua
lit
at
iv
e
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ro
up
s
M
en
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pr
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an
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A
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A
m
er
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ch
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ge
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B
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 c
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N
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s c
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-
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ey
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ng
 a
bo
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th
ei
r c
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or
ec
ta
l 
ca
nc
er
 k
no
w
l-
ed
ge
 re
ga
rd
-
in
g 
sc
re
en
in
g 
ag
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he
th
er
 
th
ey
 h
ad
 b
ee
n 
sc
re
en
ed
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nd
 
w
he
th
er
 th
ey
 
ha
d 
br
ou
gh
t u
p 
sc
re
en
in
g 
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th
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r d
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to
r
N
ic
ho
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on
 e
t a
l. 
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Q
ua
nt
ita
tiv
e
D
ou
bl
e-
bl
in
d 
R
an
do
m
iz
ed
 
St
ud
y
A
fr
ic
an
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m
er
i-
ca
n 
m
en
 a
nd
 
w
om
en
 a
ge
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an
d 
ol
de
r w
ith
 
no
 h
ist
or
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of
 c
ol
or
ec
ta
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ab
le
 to
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an
d 
re
sp
on
d 
to
 p
rin
te
d 
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fo
rm
at
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n
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40
 a
nd
 o
ld
er
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0
N
ot
 sp
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ifi
ed
Ph
ys
ic
ia
n 
an
d 
or
ga
ni
za
tio
n
G
ro
up
-b
as
ed
 
m
ed
ic
al
 m
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-
tru
st 
sc
al
e
Pa
rti
ci
pa
nt
s w
er
e 
as
ke
d 
if 
th
ey
 
ha
d 
pr
ev
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us
ly
 
be
en
 sc
re
en
ed
 
fo
r C
RC
 a
nd
 
th
e 
ex
te
nt
 to
w
hi
ch
 th
ey
 w
er
e 
pl
an
ni
ng
 o
n 
be
in
g 
sc
re
en
ed
 
in
 th
e 
ne
xt
 6
 
m
on
th
s
Ta
bl
e 
1 
 (c
on
tin
ue
d)
A
ut
ho
r(
s)
M
et
ho
d 
ty
pe
St
ud
y 
de
si
gn
 
ty
pe
Sa
m
pl
e 
ch
ar
ac
-
te
ris
tic
s
%
 A
fr
ic
an
 
A
m
er
ic
an
s
R
is
k 
su
bg
ro
up
Sa
m
pl
e 
si
ze
Ty
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(s
) o
f c
ol
o-
re
ct
al
 c
an
ce
r 
ad
dr
es
se
d
Le
ve
l o
f t
ru
st 
m
ea
su
re
d
M
ea
su
re
 o
f 
tru
st
M
ea
su
re
 o
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co
lo
re
ct
al
 
ca
nc
er
 sc
re
en
in
g 
be
ha
vi
or
O
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al
le
y 
et
 a
l. 
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Q
ua
nt
ita
tiv
e
C
ro
ss
-s
ec
tio
na
l
A
fr
ic
an
-A
m
er
-
ic
an
 w
om
en
 
ag
es
 4
0+
 w
ith
 
a 
us
ua
l s
ou
rc
e 
of
 c
ar
e
10
0%
40
 a
nd
 o
ld
er
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1
FO
B
T
Ph
ys
ic
ia
n
Su
rv
ey
 it
em
s 
fro
m
 th
e 
Pr
im
ar
y 
C
ar
e 
A
ss
es
sm
en
t 
(1
)‘
‘T
hi
nk
-
in
g 
ab
ou
t
ho
w
 m
uc
h
yo
u 
tru
st 
yo
ur
do
ct
or
, h
ow
str
on
gl
y 
do
yo
u 
ag
re
e 
or
di
sa
gr
ee
 w
ith
th
e 
fo
llo
w
in
g
st
at
em
en
t:
M
y 
do
ct
or
ca
re
s m
or
e
ab
ou
t h
ol
di
ng
do
w
n 
co
sts
th
an
 a
bo
ut
do
in
g 
w
ha
t i
s
ne
ed
ed
 fo
r m
y
he
al
th
.’’
 (2
)
‘‘A
ll 
th
in
gs
co
ns
id
er
ed
,
ho
w
 m
uc
h 
do
yo
u 
tru
st 
yo
ur
do
ct
or
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Re
sp
on
de
nt
s 
w
er
e 
as
ke
d 
ab
ou
t t
he
ir 
ad
he
re
nc
e 
to
 
co
lo
re
ct
al
 c
an
-
ce
r s
cr
ee
ni
ng
Pa
lm
er
 e
t a
l. 
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Q
ua
lit
at
iv
e
In
-d
ep
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te
r-
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A
fr
ic
an
 A
m
er
i-
ca
ns
 a
ge
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w
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 c
ol
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g
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B
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 c
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N
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A
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C
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re
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H
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in
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O
B
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w
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e 
pa
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 th
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st 
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w
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m
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ac
-
te
ris
tic
s
%
 A
fr
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R
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f c
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 c
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 o
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, b
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m
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 m
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e
Th
e 
co
lo
re
ct
al
 
ca
nc
er
 sc
re
en
-
in
g 
qu
es
tio
n-
na
ire
 (C
C
SQ
)
Sa
nd
er
s 
Th
om
ps
on
 
et
 a
l. 
[2
5]
Q
ua
nt
ita
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 b
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 m
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at
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l C
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re
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se
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A
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s
R
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Q
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ita
tiv
e
C
ro
ss
-s
ec
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na
l
A
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m
er
i-
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w
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w
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U
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w
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e
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B
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 c
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sc
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m
 
en
em
a
Ph
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ic
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an
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or
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za
tio
n
N
ot
 sp
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Th
e 
N
at
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C
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r I
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tu
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C
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C
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re
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in
g 
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et
 a
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6]
Q
ua
nt
ita
tiv
e
C
ro
ss
-s
ec
tio
na
l
In
di
vi
du
al
s 
ag
es
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ho
 
w
en
t t
o 
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se
ni
or
 c
en
t-
er
s l
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at
ed
 
in
 a
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di
ve
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e 
M
id
w
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te
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m
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an
 
ar
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%
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 a
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 o
ld
er
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FO
B
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ol
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ig
m
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-
do
sc
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y
Ph
ys
ic
ia
n 
an
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or
ga
ni
za
tio
n
N
ot
 sp
ec
ifi
ed
St
ud
y 
qu
es
tio
n-
na
ire
 d
ev
el
op
ed
 
to
 a
ss
es
s k
no
w
l-
ed
ge
 a
bo
ut
 
C
RC
 sc
re
en
in
g 
an
d 
pe
rc
ep
tio
ns
 
ab
ou
t b
ar
rie
rs
 
to
 sc
re
en
in
g
Ta
bb
ar
ah
 e
t a
l. 
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7]
Q
ua
nt
ita
tiv
e
C
ro
ss
-s
ec
tio
na
l
A
du
lts
 a
ge
 5
0 
an
d 
ol
de
r. 
In
di
vi
du
-
al
s w
er
e 
no
t 
ex
cl
ud
ed
 if
 
th
ey
 h
ad
 c
ol
o-
re
ct
al
 c
an
ce
r
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%
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 a
nd
 o
ld
er
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5
FO
B
T,
 c
ol
on
os
-
co
py
, l
ow
er
 
en
do
sc
op
y
Ph
ys
ic
ia
n 
an
d 
or
ga
ni
za
tio
n
Su
rv
ey
 it
em
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le
ve
l o
f t
ru
st 
in
 th
e 
he
al
th
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fo
rm
at
io
n 
th
ey
 re
ce
iv
ed
 
fro
m
 d
iff
er
en
t 
so
ur
ce
s
C
ol
or
ec
ta
l c
an
ce
r 
sc
re
en
in
g 
be
ha
vi
or
 a
nd
 
at
tit
ud
es
 w
er
e 
m
ea
su
re
d 
w
ith
 
ite
m
s b
as
ed
 o
n 
th
e 
Tr
ia
nd
is
 
m
od
el
 fo
r c
on
-
su
m
er
 d
ec
is
io
n-
m
ak
in
g
Ta
bl
e 
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 S
um
m
ar
y 
of
 d
om
in
an
t t
he
m
es
 fr
om
 in
cl
ud
ed
 q
ua
lit
at
iv
e 
stu
di
es
Th
em
e
D
es
cr
ip
tio
n
Sa
m
pl
e 
Q
uo
te
(s
)
C
on
tri
bu
tin
g 
St
ud
ie
s
M
ist
ru
st 
as
 a
 b
ar
rie
r t
o 
sc
re
en
in
g
Pa
rti
ci
pa
nt
s n
ot
ed
 th
at
 th
ei
r m
ist
ru
st 
of
 d
oc
-
to
rs
 a
nd
/o
r t
he
 U
.S
. h
ea
lth
 c
ar
e 
sy
ste
m
 w
ith
in
 
di
sc
us
si
on
s a
bo
ut
 b
ar
rie
rs
 to
 c
ol
or
ec
ta
l c
an
ce
r 
sc
re
en
in
g
“L
ik
e 
I s
ay
, I
 d
o 
ha
ve
 a
 fe
ar
 o
f h
os
pi
ta
ls
...
 L
ik
e 
I 
sa
id
 to
 y
ou
, i
f i
t’s
 n
ot
 b
ro
ke
, d
on
’t 
fix
 it
. L
oo
ki
ng
 
fo
r t
ro
ub
le
...
,” 
an
d 
“Y
ou
 k
no
w
 th
ey
 d
on
’t 
lik
e 
do
ct
or
s, 
th
ey
 d
on
’t 
tru
st 
do
ct
or
s.”
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3]
B
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ta
ni
 e
t a
l. 
[3
4]
, B
ra
nd
ze
l e
t a
l. 
[4
2]
, F
yff
e 
et
 a
l. 
[4
3]
, G
ao
 e
t a
l. 
[4
4]
, G
re
in
er
 e
t a
l. 
[4
5]
, G
riffi
th
 
et
 a
l. 
[3
3]
, H
ol
m
es
-R
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colonoscopy if a trusted doctor recommended it [24]. Three 
studies measured trust but did not specify which measures 
or items were used in the study [25–27].
Associations Between Medical Mistrust and CRC 
Screening for Quantitative Studies
Table  4 illustrates detected associations between medi-
cal mistrust and CRC screening outcomes by screening 
type across 14 of the 15 included quantitative studies. One 
study was omitted because results were reported by inter-
vention arms rather than direct associations of the medi-
cal mistrust-CRC relationship [54]. A positive association 
indicates studies in which higher scores of medical mistrust 
are associated with higher rates of CRC screening.  Nega-
tive association studies show higher scores of medical mis-
trust associated with lower rates in CRC screening. A con-
ditional association indicated either a positive or negative 
association, but only for certain subpopulations, such as 
gender or age group. Of the 14 studies, 18 total associations 
were captured, with 1 positive, 6 negative, 4 conditional 
and 7 studies with no association. Across included studies, 
8 associations were statistically significant (p <  0 .05), pri-
marily within negative association studies (n = 5). Because 
included studies examined multiple associations across 
subgroups, the number of associations is higher than the 
total number of quantitative studies analyzed.
Of the 11 studies examining mistrust at the physician 
level, one positive, 4 negative, 2 conditional, and 4 no 
association articles were included. The majority of statis-
tically significant associations (67%) fell in the negative 
association group, meaning that higher scores of medical 
mistrust were significantly associated with lower rates of 
colorectal cancer screening. Of the five studies examining 
mistrust at the physician and organization level, one nega-
tive, two conditional, and two no association studies were 
found. A single study [28] examined mistrust of patient 
navigators and found no significant association between 
medical mistrust and CRC screening.
Comparative Analysis of Findings Between Men 
and Women for Quantitative Studies
No studies quantitatively examined gender differences 
in the associations between mistrust and CRC screen-
ing. However, eight studies examined gender differences 
in either CRC screening adherence or medical mistrust. 
Results for the association between medical mistrust and 
CRC screening adherence among men were mixed. One 
study illustrated that men with low provider trust were 
more likely to be classified with low CRC screening latent 
profiles [29]. However, in comparative studies, men did not 
have statistically different rates of mistrust than women, 
and male gender role was not significantly associated 
with CRC screening adherence [25, 30]. Among women, 
results were also inconclusive. Greiner et  al. [45] found 
that women were significantly more likely to report bar-
riers to endoscopy screening. However, one study found 
that women were more likely to report colonoscopy receipt 
and less likely to report receiving an FOBT than men [27]. 
Additional studies found that women were not significantly 
Table 4  Associations between medical mistrust and CRC screening among African Americans for quantitative studies (n = 14)
Because many studies included multiple outcomes, the total number of associations (n = 18) exceeds the total number of included studies (n = 14)
*Significant association (p < 0.05)
a When higher scores of medical mistrust were associated with higher rates of CRC screening
b When higher scores of medical mistrust were associated with lower rates of CRC screening
c When a positive or negative association existed but only under certain conditions (e.g. differences by gender or age subgroup)
d When medical mistrust was not associated with CRC screening
Colorectal screening type Positive  associationa Negative  associationb Conditional  associationc No  associationd Total
Colonoscopy only 0 0 1 (Gordon et al.) 1 (Jandorf et al.) 2
FOBT only 0 0 1 (Born et al.)* 2 (O’ Malley 
et al.; Born 
et al.)
3
FOBT and colonoscopy 0 1 (Gupta et al.)* 0 1 (Gupta et al.) 2
FOBT, colonoscopy, sigmoidoscopy 0 3 (BeLue et. al*, Tabbarah 
et. al*, Greiner et. al*)
0 3 (Brittain et al.; 
Stacy et al.; 
Greiner et al.)
6
FOBT, Colonoscopy, Sigmoidos-
copy, Barium Enema
0 1 (Sanders Thompson, [53]) 1 (Purnell et. al*) 0 2
Not specified 1 (Bynum et. al*) 1 (Nicholson et. al*) 1 (Nicholson et al.) 0 3
Overall total 1 6 4 7 18
more likely to participate in CRC screening than men [24, 
31, 32].
Discussion
This systematic review identified 27 studies that empiri-
cally assessed relationships between medical mistrust and 
CRC screening among African Americans. Overall, results 
linking medical mistrust to CRC screening outcomes were 
mixed. However, when examined by statistical significance, 
higher medical mistrust scores were associated with lower 
rates of CRC screening in our study population. This find-
ing was notable in articles examining FOBT, colonoscopy, 
and sigmoidoscopy as well as in cases where physician 
level medical mistrust was measured. Although our quanti-
tative results did not yield definitive linkages between med-
ical mistrust and colorectal cancer, findings from included 
qualitative studies identified multiple aspects during the 
clinical interaction contributing to mistrust, highlighting 
that medical mistrust may be mitigated by positive patient-
provider interactions and shared decision-making. Qualita-
tive themes centered on aspects of patient-provider inter-
actions that contributed to mistrust, such as skepticism of 
motives, perceived equity of treatment, and competence of 
providers.
Findings from our review confirmed important deficits 
in the evidence base regarding colorectal cancer screening 
among African Americans. We found that the majority of 
quantitative articles linked medical mistrust to significantly 
lower rates of CRC screening. Furthermore, we found lim-
ited evidence evaluating organizational level mistrust and 
differences in CRC screening by gender. Studies examining 
the direct association between medical mistrust and CRC 
screening also indicate significant variability in measures 
used to capture our outcomes of interest. This finding pre-
sents emerging opportunities for future research using valid 
and reliable medical mistrust measures in order to fully 
capture the impact of mistrust in healthcare utilization and 
subsequent health outcomes. Emerging research is also 
poised to investigate more nuanced and iterative expres-
sions of mistrust in the cancer care continuum through 
longitudinal or qualitative investigations. Although CRC 
incidence is highest among African Americans, few studies 
took into account CRC risk factors in recruitment and sam-
pling strategies in this population [33, 34]. Future investi-
gations examining CRC screening barriers among African 
Americans should acknowledge early incidence and sever-
ity of CRC in these populations in the recruiting and ana-
lytic framework.
Our comparative analysis of studies investigating gen-
dered patterns of mistrust suggests that there are no dis-
tinct differences between CRC screening and mistrust 
associations between African American men and women. 
However, due to the small number of included quantita-
tive studies (n = 8) that compared findings by gender, future 
studies are needed to directly examine how gender modifies 
the relationship between medical mistrust and CRC screen-
ing. Qualitative studies highlighted patterns of mistrust, 
particularly among men, that prevented CRC screening, 
such as fear of experimentation and invasiveness of proce-
dure. These patterns may reflect gender role norms (e.g., 
beliefs about masculinity) that have scarcely been attended 
to in studies assessing CRC screening barriers. Several 
studies document associations between masculinity norms 
and disparate use of health services among African Ameri-
can men [16, 35, 36]. In one of the few studies examining 
psychosocial correlates of medical mistrust among African 
American men, Hammond determined that medical mis-
trust was largely influenced by masculinity norms discour-
aging disclosure of vulnerability [16]. Future studies inves-
tigating associations between medical mistrust and CRC 
screening should also include measures assessing gender 
norms.
This review was limited by the varied definitions and 
measures used to conceptualize medical mistrust among 
African Americans. In addition, CRC screening outcomes 
were largely assessed through self-reported surveys assess-
ing attitudes and beliefs rather than rates of CRC screening 
completion. Due to this heterogeneity in study measures, 
we were unable to complete a more in-depth meta-analy-
sis. There is also potential for publication bias due to the 
under-representation of null or negative findings in pub-
lished research. Finally, the majority of studies utilized 
cross-sectional study design, thus limiting the confirma-
tion of temporal associations between medical mistrust and 
subsequent CRC screening patterns. Reasons for employ-
ing a one-time, observational method of assessing screen-
ing behavior are not unusual, given the length of time 
between screening occurrences (i.e. generally every 5 years 
for sigmoidoscopy and 10 years for colonoscopy). How-
ever, future studies utilizing a sequential cohort design may 
mitigate issues of attrition that may arise in longitudinal 
research while simultaneously addressing issues of tempo-
rality that arise in cross-sectional studies.
Despite these limitations, this review highlights the 
importance of medical mistrust as an important construct 
in help-seeking for colorectal cancer screening. Emerg-
ing interest in the effects of medical mistrust and health 
outcomes has led to an increase in studies exploring its 
relationship among marginalized groups [37–40]. More 
recently, studies exploring the role of mistrust in the Afri-
can American community illustrate the importance of this 
construct, particularly in underutilization of preventive 
health services [15, 16]. This review highlights the influ-
ence of cultural attitudes and mistrust on preventive cancer 
services. Data synthesized in this review confirms that 
medical mistrust is a key construct in the CRC screening 
decision-making process among African Americans. Many 
studies included in this review rigorously examined the role 
of mistrust in the health care utilization process, but there is 
more to work to be done in determining the role of trust as 
African Americans move across the CRC care continuum. 
The paucity of available literature for this review highlights 
the need for additional studies to establish more conclusive 
linkages between medical mistrust and CRC screening pat-
terns. Future research should continue to explore determi-
nants of medical mistrust, both at the patient/provider and 
organizational level of the healthcare system. Addition-
ally, consistent and psychometrically sound measures are 
needed to further build the causal relationship between 
mistrust and CRC screening. Findings from this review will 
facilitate more in-depth studies and interventions assess-
ing trust-related barriers to CRC screening among African 
Americans.
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